SAN ANTONIO – A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in predicting which patients with ...
Research highlights the use of multimodal machine learning to identify non-small cell lung cancer patients predicted to derive the most benefit from combination immunotherapy The research is a ...
The Machine Learning in Biomedicine (MLBioMed) research group at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, is currently seeking a highly-motivated postdoctoral ...
Machine learning model accurately diagnoses interstitial pneumonia, matching pulmonologist expertise and predicting mortality ...
Founded in 2012, Yayi Network is a company focused on software and information technology services. The acquisition of this patent reflects the company's deep accumulation in the field of multimodal ...